SS Innovations Gains Indonesian Approval for its Surgical Robotic System

The Indonesian Ministry of Health has approved SS Innovations International Inc.’s SSi Mantra Surgical Robotic System for clinical use in the country.
 
With more than 279 million people, Indonesia is the world’s fourth-most-populous country. However, robotic surgery has been slow to reach the island nation. Indonesia’s Bunda Hospital in Jakarta acquired its first robotic surgical system in 2012 and has only completed about 700 surgeries in the past 12 years.
 
“With the entry of the SSi Mantra to the Indonesian market, we believe that we can be instrumental in increasing access to and decreasing costs of robotic surgery options,” SS Innovation’s Chairman/CEO Dr. Sudhir Srivastava said. “We look forward to broadening surgical horizons for Indonesians and continuing to expand our innovative surgical services and options across the globe.”
 
This past spring, SS Innovations marked the completion of its 100th robotic cardiac surgery cases using the SSi Mantra Surgical Robotic System. It is the first surgical robotic system made in India, and one of the only systems in the world designed to be cost-effective with broad-spectrum surgical applications. The SSi Mantra is clinically validated in more than 70 different types of surgical procedures, according to the company. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving U.S. Food and Drug Administration and CE Mark approvals next year.

Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. SS Innovations has partnered with Johns Hopkins University, installing the SSi Mantra at the University’s Minimally Invasive Surgical Training and Innovation Center (MISTIC) in Baltimore, Md. This installation is actively training new surgeons and promoting the global dissemination of advancements in medical robotics.

“I have been in the healthcare business for the past 30 years, and this is the first time I have seen such a technology,” said Mohammad Ridwan, CEO of Neuro Medika Sejahtera, SSi Mantra’d Indonesian distributor. “I was very satisfied to see the quality of the SSi Mantra and the advancement offered by the SSi Maya, the company’s mixed-reality software application. I believe that SS Innovations offers a practical and cost-effective solution to help expand robotic surgery access in Indonesia.”
 
SS Innovations International Inc. develops surgical robotic technologies in an effort to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary SSi Mantra surgical robotic system, and SSi Mudra its wide range of surgical instruments capable of supporting various surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its surgical robotic solutions globally.